Aethlon readies U.S. study of the Hemopurifier

See on Scoop.it21st Century Integrative Medicine

Aethlon Medical (OTCQB:AEMD), sporting FDA approval of an investigational drug exemption (IDE), plans to begin treating patients infected with hepatitis C virus (HCV) early next year in a feasibili…

Asher Laub‘s insight:

The Hemopurifier gives more than just hope to those infected w/ viruses as pathogenic as HIV and polio and even cancer with a drug free treatment; worth noting that it is actually used in conjunction with drug therapy for a statistical high success rate.

See on


About davidlandau

David Landau is a graduate of NYU Steinhardt and a science educator since 2007. His interests and booking musical entertainment. His favorite musical performers are Asher and Lindsey Stirling

Posted on October 22, 2013, in Uncategorized. Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: